Ronald Silver Ironwood Pharmaceuticals Inc (IRWD) insider trading activity

Ronald Silver is Principal Accounting Officer of IRONWOOD PHARMACEUTICALS INC. Currently has a direct ownership of 279,655 shares of IRWD, which is worth approximately $416,685. The most recent transaction as insider was on Feb 10, 2025, when has been sold 12,048 shares (Class A Common Stock) at a price of $1.76 per share, resulting in proceeds of $21,204. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 280K

76.58% 3M change

108.29% 12M change

Total Value Held $416,685

Ronald Silver Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 10 2025	SELL Open market or private sale	$21,204 $1.76 p/Share	12,048 Reduced 4.13%	279,655 Class A Common Stock
Jan 27 2025	BUY Grant, award, or other acquisition	-	133,333 Added 31.37%	291,703 Class A Common Stock
Aug 12 2024	SELL Open market or private sale	$13,266 $4.27 p/Share	3,107 Reduced 1.92%	158,370 Class A Common Stock
Feb 12 2024	SELL Open market or private sale	$120,517 $15.24 p/Share	7,908 Reduced 5.56%	134,264 Class A Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	27,213 Added 14.42%	161,477 Class A Common Stock
Aug 29 2023	BUY Grant, award, or other acquisition	-	8,000 Added 5.33%	142,172 Class A Common Stock
Aug 14 2023	SELL Open market or private sale	$19,839 $10.04 p/Share	1,976 Reduced 1.45%	134,172 Class A Common Stock
Mar 08 2023	BUY Grant, award, or other acquisition	-	35,620 Added 20.99%	134,111 Class A Common Stock
Feb 28 2023	SELL Open market or private sale	$34,484 $11.31 p/Share	3,049 Reduced 3.0%	98,491 Class A Common Stock
Feb 27 2023	SELL Open market or private sale	$33,419 $11.41 p/Share	2,929 Reduced 2.8%	101,540 Class A Common Stock
Nov 21 2022	SELL Open market or private sale	$7,883 $11.56 p/Share	682 Reduced 0.65%	104,469 Class A Common Stock
Aug 15 2022	SELL Open market or private sale	$23,705 $11.77 p/Share	2,014 Reduced 1.88%	105,151 Class A Common Stock
May 23 2022	SELL Open market or private sale	$1,380 $11.5 p/Share	120 Reduced 0.11%	105,073 Class A Common Stock
Mar 24 2022	SELL Open market or private sale	$38,645 $12.75 p/Share	3,031 Reduced 2.8%	105,193 Class A Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	47,013 Added 30.28%	108,224 Class A Common Stock
Feb 28 2022	SELL Open market or private sale	$24,103 $10.77 p/Share	2,238 Reduced 3.53%	61,211 Class A Common Stock
Nov 23 2021	SELL Open market or private sale	$16,930 $11.58 p/Share	1,462 Reduced 2.33%	61,213 Class A Common Stock
Aug 16 2021	SELL Open market or private sale	$7,643 $13.48 p/Share	567 Reduced 0.9%	62,675 Class A Common Stock
Jul 20 2021	BUY Grant, award, or other acquisition	-	20,000 Added 24.03%	63,242 Class A Common Stock

Ronald Silver

Principal Accounting Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IRWD shares.

Notify only if

Value

Insider Trading

Get notified when an Ironwood Pharmaceuticals Inc insider buys or sells IRWD shares.

Notify only if

Operation

Value

Type

News

Receive news related to IRONWOOD PHARMACEUTICALS INC

Track Activities on IRWD

Account